HOME >> BIOLOGY >> NEWS
Researcher receives grant to help halt HIV replication

ST. LOUIS-Duane Grandgenett, Ph.D., professor of molecular virology at the Institute of Molecular Virology (IMV) at Saint Louis University School of Medicine, has received two grants totaling nearly a million dollars to study ways of inhibiting HIV replication in humans. The grants are from the National Institute of Allergy and Infectious Diseases ($866,250) and the American Foundation for AIDS Research ($75,000).

"Busch Stadium holds about 47,000 people," Dr. Grandgenett said. "Every three days, that's approximately how many people in the world become infected with HIV. It's a huge problem to say the least and the fundamental work we're doing in the lab is vital to understanding HIV's method of operation."

The monetary awards support Dr. Grandgenett's exploration of integrase, a protein he and his colleagues at Saint Louis University discovered in 1978. Integrase is one of three HIV proteins crucial to the infection's survival. The first protein, reverse transcriptase, converts the ribonucleic acid (RNA) in HIV into deoxyribonucleic acid (DNA). Integrase then inserts the HIV DNA into the immune cell's DNA, making it a permanent part of the cell. The third protein, protease, helps the newly infected cell reproduce the virus. Millions of HIV tainted cells can be launched from a single infected cell.

Drugs such as AZT and drug combinations (cocktails) exist to inhibit reverse transcriptase and protease but, as of yet, there are no drugs to counter integrase.

"Drugs that target integrase would be a valuable accompaniment to the current inhibitors of HIV," Dr. Grandgenett said. "The current drug combinations available have side effects that are very difficult to tolerate. Finding a way to inhibit integrase could not only help us attack the virus on all three fronts but also could lessen the side effects of current therapy."

Dr. Grandgenett pointed out that studying the basic mechanisms of HIV is critical to finding effective
'"/>

Contact: Joe Muehlenkamp
muehlenk@slu.edu
314-977-8015
Saint Louis University
20-Aug-2001


Page: 1 2

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Researchers identify protein promoting vascular tumor growth
4. Researchers devise potent new tools to curb ivory poaching
5. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
6. Researchers ID chlorophyll-regulating gene
7. Researchers develop fast track way to discover how cells are regulated
8. Researchers identify distinctive signature for metastatic prostate cancer
9. Researchers report new gene test for isolated cleft lip and palate
10. Researchers discover why mutant gene causes colon cancer
11. Researchers identify the genomes controlling elements

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/7/2020)... ... 06, 2020 , ... Nine middle school teachers from eight ... a unique professional development program that provides advanced STEM (science, technology, engineering and ... nationwide. , Created in partnership between the National Stem Cell Foundation and The ...
(Date:7/31/2020)... ... July 30, 2020 , ... Justin ... portfolio with a near term focus on Type 2 diabetes and associated comorbidities. ... across multiple therapeutic areas and classes. As Chief Commercial Officer, Justin will lead ...
(Date:7/10/2020)... , ... July 08, 2020 , ... ... Cell and Gene Therapy Regulation, An FDAnews Webinar, Wednesday, July 22, 2020 • ... comparability study, but what is the most effective way to complete one? Will ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... ... radar transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and ... can drive one or two switches in a push-pull configuration; yielding fast fall ...
(Date:7/31/2020)... ... ... eSource has long been touted as the solution to high data management and monitoring ... did not take off as quickly as people initially expected, and where eSource is ... data electronically for clinical trials and then repurposing it for downstream analysis, at a ...
(Date:7/22/2020)... ... 2020 , ... Join experts from Reed Tech , Gary Saner, Sr. ... one hour live webinar on Thursday, August 13, 2020 at 11am EDT ... medical devices. Specifically, for medical devices, the NMPA has departments dealing with medical device ...
(Date:7/18/2020)... ... July 16, 2020 , ... Medial EarlySign , ... and prevention of high-burden diseases, and Centric Consulting, a business and technology consulting ... utilize existing data in order to identify and prioritize patients for care. , ...
Breaking Biology Technology:
Cached News: